Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing
Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277